Invest in TheraV

On a mission to transform & innovate post-amputation therapy and rehabilitation

$1,250

reserved of a $50,000 goal
INVESTMENT TERMS
Future Equity
$2.5M valuation cap
$250, $500, $1K

Highlights

1
🔏 Patent-pending Technology
2
🤝 Over 100 paid Beta Users
3
💰 Over $450K raised to date
4
Tapping into a $13B amputation pain market in the USA

Our Founder

While working with patients at a prosthetic clinic, I was exposed to the mental and physical pain that came with limb loss. Specifically, I was exposed to the issue of phantom limb pain, an incurable condition that affected 80% of the amputee community. The personal stories of patients at the clinic inspired me to address this problem.

Pitch

Overview